Advertisement

Ads Placeholder
Loading...

Curatis Holding AG

CURN.SWSIX
Healthcare
Drug Manufacturers - Specialty & Generic
CHF22.50
CHF0.90(4.17%)
Swiss Market opens in 51h 21m

Curatis Holding AG Fundamental Analysis

Curatis Holding AG (CURN.SW) shows weak financial fundamentals with a PE ratio of -79.27, profit margin of -13.11%, and ROE of -3.09%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.79
Current Ratio1.65

Areas of Concern

ROE-3.09%
Operating Margin-14.31%
Cash Position1.66%
We analyze CURN.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 18.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
18.2/100

We analyze CURN.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

CURN.SW struggles to generate sufficient returns from assets.

ROA > 10%
-2.53%

Valuation Score

Excellent

CURN.SW trades at attractive valuation levels.

PE < 25
-79.27
PEG Ratio < 2
-0.79

Growth Score

Weak

CURN.SW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CURN.SW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.65

Profitability Score

Weak

CURN.SW struggles to sustain strong margins.

ROE > 15%
-308.91%
Net Margin ≥ 15%
-13.11%
Positive Free Cash Flow
No

Key Financial Metrics

Is CURN.SW Expensive or Cheap?

P/E Ratio

CURN.SW trades at -79.27 times earnings. This suggests potential undervaluation.

-79.27

PEG Ratio

When adjusting for growth, CURN.SW's PEG of -0.79 indicates potential undervaluation.

-0.79

Price to Book

The market values Curatis Holding AG at 2.44 times its book value. This may indicate undervaluation.

2.44

EV/EBITDA

Enterprise value stands at -104.51 times EBITDA. This is generally considered low.

-104.51

How Well Does CURN.SW Make Money?

Net Profit Margin

For every $100 in sales, Curatis Holding AG keeps $-13.11 as profit after all expenses.

-13.11%

Operating Margin

Core operations generate -14.31 in profit for every $100 in revenue, before interest and taxes.

-14.31%

ROE

Management delivers $-3.09 in profit for every $100 of shareholder equity.

-3.09%

ROA

Curatis Holding AG generates $-2.53 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.53%

Following the Money - Real Cash Generation

Operating Cash Flow

Curatis Holding AG generates limited operating cash flow of $-1.35M, signaling weaker underlying cash strength.

$-1.35M

Free Cash Flow

Curatis Holding AG generates weak or negative free cash flow of $-2.61M, restricting financial flexibility.

$-2.61M

FCF Per Share

Each share generates $-0.51 in free cash annually.

$-0.51

FCF Yield

CURN.SW converts -2.18% of its market value into free cash.

-2.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-79.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.79

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.44

vs 25 benchmark

P/S Ratio

Price to sales ratio

10.73

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.65

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How CURN.SW Stacks Against Its Sector Peers

MetricCURN.SW ValueSector AveragePerformance
P/E Ratio-79.2728.45 Better (Cheaper)
ROE-3.09%763.00% Weak
Net Margin-13.11%-45265.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio1.652795.60 Neutral
ROA-2.53%-16588.00% (disorted) Weak

CURN.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Curatis Holding AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ